查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1694040

歐洲醫藥塑膠包裝：市場佔有率分析、產業趨勢與統計、成長預測（2025-2030）

Europe Pharmaceutical Plastic Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 133 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2025年歐洲醫藥塑膠包裝市場規模為144億美元，到2030年將達到185.2億美元，預測期內（2025-2030年）的複合年成長率為5.17%。

歐洲醫藥塑膠包裝市場-IMG1

塑膠包裝材料和產品具有重量輕、成本低、柔韌性、機械強度和穩定性等優勢，適合在歐洲醫藥包裝市場使用。

關鍵亮點

  • 泡殼包裝在藥品包裝中的應用日益廣泛，方便儲存和運輸錠劑和膠囊等固態藥物，這推動了對塑膠包裝的需求。
  • 由於塑膠瓶不易破損且重量較輕，歐洲製藥公司越來越傾向於使用塑膠瓶來包裝止咳糖漿和其他液體藥物，以提高利潤率，從而支持塑膠包裝在研究市場的成長。
  • 硬質塑膠瓶和管瓶具有出色的阻隔性，可保護藥物免受潮濕和污染。它重量輕、易於操作且有多種尺寸可供選擇，支持了塑膠包裝在製藥行業的發展。軟性塑膠袋和泡殼包裝方便分配單一劑量或隨時隨地服用。
  • 歐洲更先進的醫療保健基礎設施的發展正在推動醫藥塑膠包裝市場的發展。先進的醫療機構通常擁有強大的低溫運輸基礎設施來儲存和運輸疫苗等對溫度敏感的藥物，因此會考慮到疫苗低溫運輸要求等物流方面的問題。
  • 紅海危機源自於以色列與哈馬斯的衝突。紅海商船和海軍艦艇遭受飛彈襲擊，擾亂了從中東國家到歐洲的樹脂和塑膠原料供應鏈路線，導致生態系統原料價格上漲，阻礙了市場成長。
  • 2024年4月，各類軟包裝製造商的行業協會Flexible Packaging Europe報告稱，紅海航運中斷造成的供應鏈中斷對供應鏈產生了重大影響，導致2024年第一季歐洲軟包裝材料（包括塑膠包裝材料）價格上漲，對歐洲市場的成長產生了負面影響。

歐洲醫藥塑膠包裝市場趨勢

注射器市場預計將佔據主要市場佔有率

  • 歐洲人口不斷成長，加上人口老化和慢性病急劇增加，刺激了對注射器和注射藥物的需求。同時，主要企業受到有關醫用針頭使用法規不斷發展的驅動，推動醫療技術的進步和創新。
  • 注射器已成為腸外給藥的重要工具。特別是用於從管瓶中提取和注射藥物的預填充注射器越來越受到關注。這些注射器主要用於治療癌症和糖尿病等慢性疾病，可精確輸送藥物並最大限度地減少針頭暴露，從而提高患者的安全性。
  • 考慮到慢性病的增加、對注射藥物的偏好日益成長以及注射器領域的持續技術進步，預填充注射器市場預計在未來幾年將會成長。 IDF糖尿病地圖集第10版預測歐洲糖尿病患者數將大幅增加，預計2030年將達6,700萬人，2045年將達6,900萬人。
  • 塑膠注射器正成為越來越受歡迎的醫療耗材，取代金屬和玻璃等傳統材料。這一趨勢的一個顯著例子是採用射出成型聚丙烯樹脂製成的一次性注射器。這些注射器包括一個柱塞、一個用於指示容量的刻度體、一個墊圈、一個針頭支架和一個保護鞘套。拋棄式注射器在現代醫學中應用十分廣泛，主要用於注射藥物、疫苗以及抽血等。它們比可重複使用的注射器更受歡迎，因為它們可以降低疾病傳播的風險。典型的應用包括給糖尿病患者注射胰島素和給牙醫局部麻醉。
  • 隨著臨床測試速度的加快，用於分析的樣本量也在增加，因此需要有效地收集、儲存和運輸這些樣本。分散式和虛擬臨床實驗（遠端收集樣本）的趨勢日益成長，這正在產生對溫控塑膠包裝的需求。根據再生醫學聯盟的數據，2023年歐洲進行了329項再生醫學臨床試驗。
  • 基於此需求，2024年4月，在今年6月於斯圖加特舉辦的Medtec Europe展會上，德國射出成型機製造商阿博格（Arburg）推出了採用不鏽鋼材質的電動Allrounder。此機器設計用於使用環狀烯烴聚合物（COP）代替玻璃來製造注射器筒。新發布的 Allrounder 370 A 採用符合 GMP 標準的不銹鋼製成，專為無塵室工作而設計。其扣夾力600 kN，注射單元尺寸為 70。鎖模單元的上部配備了 Ronstatex 潔淨空氣模組，以確保清潔的生產環境。

德國：預計將出現顯著成長

  • 由於人口結構的變化以及人們對預防性自我治療的興趣日益濃厚，德國製藥業正在經歷強勁成長。這些因素凸顯了該市場的巨大成長潛力。德國是世界領先的臨床檢測提供國之一，其許多正在進行的研究計畫為醫學進步做出了貢獻。由於大量的研發投入和眾多的專利申請，德國在歐洲醫藥創新領域處於領先地位。根據德國貿易投資署統計，德國是世界第二大醫藥出口國，其製造業位居世界前列。
  • 預計德國政府的舉措將在推動醫藥塑膠包裝市場方面發揮關鍵作用。特別是，2023年德國政府發布了新的製藥策略，概述在戰略文件4.0。該策略旨在加強該國的製藥業，重點是提高研究和生產能力以及簡化市場准入和定價機制。該策略包括大力投資研發、獎勵製藥公司創新以及簡化監管流程的措施。這些改革預計將吸引大量外國投資，刺激國內生產，並確保德國繼續處於製藥業進步的前沿。
  • 主要企業正在加大投資，擴大在德國的業務。投資的激增將直接促進醫藥領域塑膠包裝的生產，成為市場的主要成長動力。
  • 例如，2024年2月，全球機構投資者安大略省教師退休金計畫委員會和以專注於醫療保健投資而聞名的Nordic Capital宣布與Advanz Pharma建立策略合作夥伴關係。 Advanz Pharma 在歐洲製藥業佔有重要地位，此次合作將使其能夠加強成長和發展舉措。 Advanz Pharma 的業務範圍遍布 90 多個國家，專門從事專科、醫院和罕見疾病藥物。
  • 2024 年 9 月，德國醫療包裝公司 Sanner 將在本斯海姆開設一個高度自動化的包裝製造工廠。歐洲專利局授予德國製藥領域申請人的專利對於推動德國製藥塑膠包裝市場的創新和成長至關重要，凸顯了該領域持續適應的必要性。
  • 2023年，歐洲專利局向德國申請人授予了172項醫藥領域專利。德國以其強大的工業基礎和嚴格的品質標準而聞名，在歐洲醫藥塑膠包裝市場佔有舉足輕重的地位。德國對製造業的精確性和可靠性的重視保證了高品質的包裝解決方案。德國對永續性和智慧包裝等先進包裝技術的承諾預計將推動市場成長並使該國成為該領域的領導者。

歐洲醫藥塑膠包裝產業概況

歐洲醫藥塑膠包裝市場高度細分，主要參與者包括 Gerresheimer AG、Amcor PLC、Berry Global Group Inc.、Aptar Group Inc. 和 Origin Pharma Packaging。市場的主要企業正在採取合作和收購等策略來加強其產品供應並獲得永續的競爭優勢。

  • 2024年4月，Berry Global Group Inc.對資產和製造能力進行了額外投資，將歐洲三個地點的醫療生產能力提高高達30%。透過這項投資，Berry 將提供包裝和藥物輸送設備，透過改善藥物管理和依從性來提升患者體驗。
  • 2024 年 6 月，Aptar Digital Health 與 SHL Medical 合作，後者是一家先進藥物輸送系統供應商，包括自動注射器、筆式注射器和創新專業輸送系統。透過整合 Aptar Digital Health 的 SaMD 平台，SHL Medical 正在擴展連網型設備技術。此次合作旨在幫助患者管理疾病並提供全面的解決方案，特別是那些接受注射治療的患者。

其他福利

  • Excel 格式的市場預測 (ME) 表
  • 3個月的分析師支持

目錄

第1章 引言

  • 研究假設和市場定義
  • 研究範圍

第2章調查方法

第3章執行摘要

第4章 市場洞察

  • 市場概覽
  • 產業吸引力-波特五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度
  • 產業價值鏈分析
  • 評估宏觀經濟趨勢對市場的影響

第5章市場動態

  • 市場促進因素
    • 對硬質和軟質藥用塑膠產品的需求不斷增加
    • 建造更好、更先進的醫療基礎設施
  • 市場問題
    • 限制藥用塑膠製品銷售和供應的規定
    • 供應商議價能力導致原物料成本波動

第6章市場區隔

  • 按原料
    • 聚丙烯（PP）
    • 聚對苯二甲酸乙二醇酯（PET）
    • 低密度聚乙烯（LDPE）
    • 高密度聚苯乙烯（HDPE）
    • 其他
  • 依產品類型
    • 固態容器
    • 滴管瓶
    • 滴鼻劑瓶
    • 液體瓶
    • 口腔護理
    • 小袋
    • 管瓶/安瓿瓶
    • 墨水匣
    • 注射器
    • 瓶蓋和瓶塞
    • 其他
  • 按國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利

第7章競爭格局

  • 公司簡介
    • Gerresheimer AG
    • Amcor PLC
    • Berry Global Group Inc.
    • Aptar Group Inc.
    • Origin Pharma Packaging
    • Pretium Packaging
    • Klockner Pentaplast
    • Comar
    • Gil Plastic Products Ltd
    • Drug Plastics Group
    • West Pharmaceutical Services Inc.

第8章投資分析

第9章：未來市場展望

簡介目錄
Product Code: 50002527

The Europe Pharmaceutical Plastic Packaging Market size is estimated at USD 14.40 billion in 2025, and is expected to reach USD 18.52 billion by 2030, at a CAGR of 5.17% during the forecast period (2025-2030).

Europe Pharmaceutical Plastic Packaging - Market - IMG1

Advantages associated with plastic packaging materials and products, such as their lightweight, low cost, flexibility, mechanical strength, and stability, make them suitable for use in the European pharmaceutical packaging market.

Key Highlights

  • The growing adoption of blister packs in pharmaceutical packaging, which provides convenient methods to store and transport solid medicinal products, such as tablets and capsules, is fueling the demand for plastic packaging.
  • Due to the low fragile nature and light weight of plastic bottles, European pharmaceutical companies increasingly prefer plastic bottles for cough syrups and other liquid drug packaging for better profit margins, supporting the growth of plastic packaging in the studied market.
  • Rigid plastic bottles and vials offer better barrier properties, protecting medication from moisture and contamination. They are lightweight, easy to handle, and come in various sizes, supporting the growth adoption of plastic packaging in the pharmaceutical industry. Flexible plastic pouches and blister packs are convenient for unit-does dispensing and on-the-go medication use.
  • The development of better and advanced healthcare infrastructure in Europe is driving the pharmaceutical plastic packaging market, considering logistical aspects like cold chain requirements for vaccines since advanced healthcare facilities usually have robust cold chain infrastructure for storing and transporting temperature-sensitive medications like vaccines.
  • The Red Sea crisis emerged from the Israel and Hamas conflict. It generated missile attacks against merchant and naval vessels in the Red Sea, which disrupted the supply chain route of resins and plastic raw materials to Europe from Middle Eastern countries, raising the price of raw materials in the ecosystem thereby hindering the market's growth.
  • In April 2024, Flexible Packaging Europe, the industry association for all types of flexible packaging manufacturers, reported that supply chain disruptions due to the shipping disruptions in the Red Sea had a significant impact on supply chains, leading to increased prices of European flexible packaging materials, including plastic packaging material, in the first quarter of 2024. This negatively impacted the growth of the European market.

Europe Pharmaceutical Plastic Packaging Market Trends

Syringes Segment is Expected to Hold Significant Market Share

  • The rise in population in Europe is accompanied by a surge in aging demographics and chronic diseases, fueling the demand for syringes and injectables. Concurrently, key players are driving medical technology advancements and innovations bolstered by evolving regulations on medical needle usage.
  • Syringes have become the go-to tools for parenteral medication administration. Specifically, pre-fillable syringes, designed for extracting and administering drug substances from vials, are gaining prominence. These syringes, predominantly used for chronic conditions like cancer and diabetes, offer precise drug delivery and minimize needle exposure, enhancing patient safety.
  • Given the uptick in chronic diseases, the rising preference for injectable medications, and ongoing technological strides in the syringe sector, the pre-fillable syringes market is poised for growth in the coming years. The IDF Diabetes Atlas 10th edition projects a significant rise in diabetes cases in Europe, with estimates reaching 67 million by 2030 and 69 million by 2045.
  • Plastic syringes are increasingly prevalent in medical disposables, supplanting traditional materials such as metals and glass. A notable instance in this trend is the adoption of disposable syringes made from polypropylene resin through injection molding. These syringes include a plunger, a graduated main body for capacity indication, a gasket, a needle holder, and a protective sheath cover. Disposable syringes find widespread use in modern medicine, primarily for drug and vaccine injections and blood extractions. They are favored over reusable syringes to mitigate disease transmission risks. Typical applications include insulin injections for diabetics and local anesthesia administration by dentists.
  • The accelerated pace of clinical trials translates to a higher volume of samples collected for analysis, requiring efficient collection, storage, and transportation of these samples. The growing trend of decentralized and virtual trials, where samples are collected at remote locations, creates demand for temperature-controlled plastic packaging. According to the Alliance for Regenerative Medicine, 329 active clinical trials for regenerative medicine were done in Europe in 2023.
  • Considering the demand, in April 2024, at Medtec Europe in Stuttgart this June, Arburg, a German manufacturer of injection molding machines, unveiled its stainless steel electric Allrounder. This machine is designed to produce syringe barrels using cyclic olefin polymer (COP) as a glass alternative. The showcased Allrounder 370 A, crafted from stainless steel to meet GMP standards, is tailored for cleanroom operations. Boasting a clamping force of 600 kN and an injection unit size of 70, it features a Lonstatex clean air module above the clamping unit, ensuring pristine production conditions.

Germany Expected to Witness Significant Growth

  • Germany's pharmaceutical industry is experiencing considerable growth, driven by demographic shifts and a heightened focus on prevention and self-medication. These factors highlight the market's substantial growth potential. Germany is a global destination for clinical trials, with numerous ongoing studies contributing to medical advancements. Supported by significant R&D investments and many patent applications, the country leads Europe in pharmaceutical innovation. According to Germany Trade and Invest, Germany is the world's second-largest exporter of medicinal products, with a robust manufacturing sector that ranks among the top pharmaceutical producers globally.
  • Government initiatives in Germany are set to play a pivotal role in propelling the pharmaceutical plastic packaging market. Notably, in 2023, the German government unveiled a new pharmaceutical strategy outlined in Strategy Paper 4.0. This strategy, designed to fortify the nation's pharmaceutical sector, focuses on bolstering research and production capabilities and aims to streamline market access and pricing mechanisms. The strategy includes significant investments in R&D, incentives for pharmaceutical companies to innovate, and measures to enhance the efficiency of regulatory processes. These reforms are expected to attract substantial foreign investment, stimulate domestic production, and ensure that Germany remains at the forefront of pharmaceutical advancements.
  • Leading pharmaceutical companies are increasing investments in expansion activities in Germany. This investment surge is directly enhancing the production of plastic packaging in the pharmaceutical sector, serving as a key growth driver for the market.
  • For instance, in February 2024, the Ontario Teachers' Pension Plan Board, a global institutional investor, and Nordic Capital, known for its focus on healthcare investments, unveiled a strategic collaboration with Advanz Pharma. A key player in the European pharmaceutical landscape, Advanz Pharma is set to benefit from this partnership, which is designed to bolster its growth and development initiatives. With a footprint spanning 90+ nations, Advanz specializes in pharmaceuticals catering to specialty, hospital, and rare diseases.
  • In September 2024, Sanner, a German healthcare packaging company, will inaugurate a highly automated packaging production facility in Bensheim. Patents the European Patent Office granted to German applicants in the pharmaceutical sector are crucial in driving innovation and growth within Germany's pharmaceutical plastic packaging market, highlighting the sector's need for continuous adaptation.
  • In 2023, the European Patent Office granted 172 patents in the pharmaceutical sector to German applicants. Germany, known for its strong industrial base and rigorous quality standards, is pivotal in the European pharmaceutical plastic packaging market. The country's emphasis on precision and reliability in manufacturing ensures high-quality packaging solutions. Germany's commitment to sustainability and advanced technologies, such as smart packaging, is expected to fuel market growth, making it a leader in this sector.

Europe Pharmaceutical Plastic Packaging Industry Overview

The European pharmaceutical plastic packaging market is highly fragmented, with major players like Gerresheimer AG, Amcor PLC, Berry Global Group Inc., Aptar Group Inc., and Origin Pharma Packaging. Key players in the market are adopting strategies such as partnerships and acquisitions to enhance their product offerings and gain sustainable competitive advantage.

  • In April 2024, Berry Global Group Inc. invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three European sites. With this investment, Berry planned to deliver packaging and drug delivery devices that enhance the patient experience through improved medicine administration and adherence.
  • In June 2024, Aptar Digital Health collaborated with SHL Medical, a provider of advanced drug delivery systems such as autoinjectors, pen injectors, and innovative specialty delivery systems. By integrating Aptar Digital Health's SaMD platform, SHL Medical is expanding its connected device technologies. This collaboration aims to offer holistic solutions, aiding patients in managing their diseases, especially those on injectable therapies.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Degree of Competition
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the Impact of the Macroeconomic Trends on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Rigid and Flexible Pharmaceutical Plastic Products
    • 5.1.2 Development of Better and More Advanced Healthcare Infrastructure
  • 5.2 Market Challenges
    • 5.2.1 Regulations Restricting the Sale and Availability of Pharmaceutical Plastic Products
    • 5.2.2 Fluctuations in Raw Material Cost Due to Suppliers Bargaining Power

6 MARKET SEGMENTATION

  • 6.1 By Raw Material
    • 6.1.1 Polypropylene (PP)
    • 6.1.2 Polyethylene Terephthalate (PET)
    • 6.1.3 Low Density Polyethylene (LDPE)
    • 6.1.4 High Density Polyethylene (HDPE)
    • 6.1.5 Other Types of Materials
  • 6.2 By Product Type
    • 6.2.1 Solid Containers
    • 6.2.2 Dropper Bottles
    • 6.2.3 Nasal Spray Bottles
    • 6.2.4 Liquid Bottles
    • 6.2.5 Oral Care
    • 6.2.6 Pouches
    • 6.2.7 Vials and Ampoules
    • 6.2.8 Cartridges
    • 6.2.9 Syringes
    • 6.2.10 Caps and Closures
    • 6.2.11 Other Product Types
  • 6.3 By Country
    • 6.3.1 United Kingdom
    • 6.3.2 Germany
    • 6.3.3 France
    • 6.3.4 Spain
    • 6.3.5 Italy

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Gerresheimer AG
    • 7.1.2 Amcor PLC
    • 7.1.3 Berry Global Group Inc.
    • 7.1.4 Aptar Group Inc.
    • 7.1.5 Origin Pharma Packaging
    • 7.1.6 Pretium Packaging
    • 7.1.7 Klockner Pentaplast
    • 7.1.8 Comar
    • 7.1.9 Gil Plastic Products Ltd
    • 7.1.10 Drug Plastics Group
    • 7.1.11 West Pharmaceutical Services Inc.

8 INVESTMENT ANALYSIS

9 FUTURE OUTLOOK OF THE MARKET